Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Visit old site
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 238

 Table of Contents  
Year : 2016  |  Volume : 8  |  Issue : 3  |  Page : 163-166

Pancreaticoureteral fistula: A rare complication of chronic pancreatitis

1 Department of Medicine, Division of Gastroenterology, St. Joseph's Regional Medical Center, Paterson, New Jersey, USA
2 Department of Medicine, Trinitas Regional Medical Center, Elizabeth; Department of Medicine, Seton Hall University School of Health and Medical Sciences, South Orange, New Jersey, USA

Date of Web Publication21-Mar-2016

Correspondence Address:
Sohail N Shaikh
St. Joseph's Regional Medical Center, 703 Main Street, Paterson, NJ, 07503
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1947-2714.179134

Rights and Permissions

Context: Chronic pancreatitis is an inflammatory condition that may result in progressive parenchymal damage and fibrosis which can ultimately lead to destruction of pancreatic tissue. Fistulas to the pleura, peritoneum, pericardium, and peripancreatic organs may form as a complications of pancreatitis. This case report describes an exceedingly rare complication, pancreaticoureteral fistula (PUF). Only two additional cases of PUF have been reported. However, they evolved following traumatic injury to the ureter or pancreatic duct. No published reports describe PUF as a complication of pancreatitis. Case Report: A 69-year-old Hispanic female with a past medical history of cholecystectomy, pancreatic pseudocyst, and recurrent episodes of pancreatitis presented with severe, sharp, and constant abdominal pain. Upon imaging, a fistulous tract was visualized between the left renal pelvis (at the level of an upper pole calyx) and the pancreatic duct and a ureteral stent was placed to facilitate fistula closure. Following the procedure, the patient attained symptomatic relief and oral intake was resumed. A left retrograde pyelogram was repeated 2 months after the initial stent placement and demonstrating no evidence of a persistent fistulous tract. Conclusion: Due to PUF's unclear etiology and possible variance of presentation, it is important for physicians to keep this rare complication of pancreatitis in mind, especially, when evaluating a patient with recurrent pancreatitis, urinary symptoms and abnormal imaging within the urinary collecting system and pancreas.

Keywords: Chronic pancreatitis, complication, fistula, fistulous tract, pancreas, pancreatitis, pancreaticoureteral, pancreaticoureteral fistula (PUF), ureter

How to cite this article:
Patel HG, Cavanagh Y, Shaikh SN. Pancreaticoureteral fistula: A rare complication of chronic pancreatitis. North Am J Med Sci 2016;8:163-6

How to cite this URL:
Patel HG, Cavanagh Y, Shaikh SN. Pancreaticoureteral fistula: A rare complication of chronic pancreatitis. North Am J Med Sci [serial online] 2016 [cited 2023 Jun 6];8:163-6. Available from: https://www.najms.org/text.asp?2016/8/3/163/179134

  Introduction Top

Chronic pancreatitis is an inflammatory condition that may result in progressive parenchymal damage and fibrosis. The destruction of pancreatic tissue can lead to exocrine as well as endocrine dysfunction in addition to biliary, duodenal or gastric obstruction, pseudocysts, pancreatic ascites, pleural effusion, splenic or portal vein thromboses, splenic artery pseudoaneurysm, cancer and pancreatic fistulae. Pancreatic fistulae have been reported to involve the pleura, peritoneum, pericardium, and other peripancreatic organs (i.e., esophagus, stomach, duodenum, and colon). [1],[2],[3],[4] This case report describes a pancreaticouretral fistula - An exceedingly rare complication of pancreatitis, manifested as a fistula between the pancreatic duct and the ureter.

  Case Presentation Top

A 69-year-old Hispanic female with a history of recurrent episodes of pancreatitis and cholecystectomy presented with complaints of severe, sharp, and constant abdominal pain in the left upper quadrant (LUQ) and flank with radiation to the left lower quadrant (LLQ). The pain was associated with subjective fever, nausea, and nonbloody emesis and was exacerbated by oral intake. The patient denied additional gastrointestinal or genitourinary disturbances, sick contacts, travel, or consumption of unusual food.

Two months prior to presentation, she had an episode of pancreatitis complicated by pseudocyst formation along the greater curvature of the stomach, measuring 13 × 9.5 × 5.5 cm. She underwent ultrasound-guided drainage of approximately 100 mL of cloudy fluid with subsequent placement of a 12-French pigtail catheter. External bag drainage was continued for 2 weeks and removed once the drainage was minimal.

One day after catheter removal, the patient developed progressive abdominal discomfort, which prompted repeat evaluation. Laboratory studies were only significant for an alkaline urine pH of 8.0. A computed tomography (CT) scan of the abdomen revealed a cystic structure with fistulous extension below the pancreas into the left para-aortic space. The reading further commented on the presence of mild left hydronephrosis due to the passage of the ureter near a cluster of lymph nodes and cystic structures from the fistula below the pancreatic tail measuring 2.2 × 3.9 × 4.5 cm [Figure 1].
Figure 1: Coronal CT scan demonstrating pancreatic pseudocyst (arrow) extending toward the left renal collecting system

Click here to view

Magnetic resonance cholangiopancreatography (MRCP) was obtained to further evaluate the pancreatobiliary anatomy. It demonstrated an abnormal pancreatic duct in the body and tail of the pancreas with a complex multiloculated pseudocyst extending anteriorly into the lesser sac, posteriorly and medially to the level of the left kidney with possible ureteral fistula formation, and mild left-sided hydronephrosis [Figure 2] and [Figure 3]. An additional smaller fistula was noted to extend medially from the pseudocyst into a soft-tissue mass.
Figure 2: Axial T2-weighted sequence demonstrating the proximity of the pancreatic pseudocyst (arrow head) and the ureter (long arrow)

Click here to view
Figure 3: 3D MRCP shows a fistula (long arrow) between the pancreatic pseudocyst (arrow head) and left renal collecting system (short arrow)

Click here to view

In an effort to optimize pancreatic drainage, a sphincterotomy was performed with pancreatic stent placement during an endoscopic retrograde cholangiopancreatography (ERCP). Additionally, a left retrograde pyelogram was performed to evaluate the level/degree of ureteral obstruction and further assess for the presence of a fistulous tract. A fistulous tract was in fact visualized between the left renal pelvis (at the level of an upper pole calyx) and the pancreatic duct and a ureteral stent was placed to facilitate fistula closure [Figure 4]. The patient was started on imipenem/cilastatin prophylaxis pending blood and pancreatic pseudocyst fluid cultures, which ultimately returned culture negative.
Figure 4: Left retrograde pyelogram demonstrating a fistulous tract between the left renal pelvis (at the level of an upper pole calyx) and the pancreatic duct. A ureteral stent was placed to facilitate fistula closure

Click here to view

The patient remained intolerant of oral intake and experienced pain, even after the placement of pancreatic and ureteral stents. In an effort to relieve compression of the stomach by the pseudocyst and to facilitate eating, she underwent a successful pancreatic cyst gastrostomy. Following the procedure, the patient attained symptomatic relief and oral intake was successfully resumed. A left retrograde pyelogram was repeated after 2 months demonstrating no evidence of a residual fistulous tract [Figure 5].
Figure 5: Left retrograde pyelogram, repeated 2 months after initial intervention for PUF, demonstrating no evidence of a fistulous tract

Click here to view

  Discussion Top

Pancreaticoureteral fistulae (PUF) are exceedingly rare. Upon reviewing the literature only two case reports were identified. [5],[6] However, unlike our case, those fistulae evolved following traumatic injury to the ureter or pancreatic duct. No reports were found to describe PUF as a complication of chronic pancreatitis. In trauma related cases, pancreatic fistula most likely form secondary to persistent leakage of pancreatic secretions from a disrupted pancreatic duct. This may lead to persistent inflammation and result in erosion into surrounding structures. Many etiologies, including pancreatitis, trauma, biopsy, or surgery, can result in pancreatic duct disruption. [1],[7],[8] One proposed etiology for the evolution of a PUF in our patient may involve recurrent inflammatory infiltrate progressively eroding surrounding structures and intimately extending into the retroperitoneal space.

Multiple modalities are available to diagnose pancreatic fistula. ERCP, MRCP, CT scan, and fistulography are often the main imaging studies implemented. ERCP was found to be 100% sensitive and specific in the diagnosis of pancreatic ductal rupture in one prospectively study and was superior to CT scan [9],[10] and MRCP, which are reported to detect pancreatic duct abnormalities with similar accuracy. [11] In addition to the common complications of pancreatic fistulae, complications specific for PUF can include metabolic abnormalities (hyperchloremic metabolic acidosis, electrolytes imbalance), urological complications (chemical cystitis, urethritis, hematuria, urinary tract infection, and bladder stones), and reflux pancreatitis. [12],[13],[14],[15],[16] Metabolic complications are due to a loss of alkaline exocrine pancreatic secretions in the urine while pancreatic enzymes secreted in the urine may cause urological complications.

Up to 50% of internal pancreatic fistulas and 70% to 90% of external pancreatic fistulas may heal with conservative measures. [17] For patients presenting with a main pancreatic duct dilatation, without ductal disruption or stricture, conservative therapy (broad spectrum antibiotics, enteral nutrition, and correction of fluid and electrolyte imbalances) should be pursued. [18] Of note, enteral nutrition is associated with significantly higher closure rates and shorter time to closure, than parenteral nutrition. [19] Additionally, somatostatin analog administration is reported to promote pancreatic fistula closure by decreasing the volume of fistulous tract output. [20],[21],[22]

If conservative measures fail or if the fistula becomes complicated by infection or bleeding, endoscopic or surgical interventions are warranted. [1] ERCP is a safe and effective modality and can be considered the first-line therapy in the management of pancreatic fistulae. Early ERCP and pancreatic stent insertion promote fistula resolution and may allow delay or avoidance of surgical measures. [23],[24],[25],[26],[27] Due to their significant complication profile, surgical interventions should be reserved for cases not responsive to conservative measures.

  Conclusion Top

Pancreatic fistula formation is a rare complication of pancreatitis. PUF, in particular, is an exceedingly unusual manifestation of a pancreatic fistula. A number of imaging modalities, such as ERCP, MRCP, CT scan, or fistulography, can assist in the diagnosis of PUF. Nonoperative modalities, including medical and endoscopic measures, may initially be pursued for the management of PUF. Failure of these conservative approaches may warrant pursuit of surgical measures.

Due to PUF's unclear etiology and possible variance of presentation, it is important for physicians to keep this rare complication of pancreatitis in mind while evaluating patients with recurrent pancreatitis, urinary symptoms, and/or imaging suggestive of abnormalities within the urinary collecting system and pancreas.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

  References Top

Alexakis N, Sutton R, Neoptolemos JP. Surgical treatment of pancreatic fistula. Dig Surg 2004;21:262-74.  Back to cited text no. 1
Cullen JJ, Sarr MG, Ilstrup DM. Pancreatic anastomotic leak after pancreaticoduodenectomy: Incidence, significance, and management. Am J Surg 1994;168:295-8.  Back to cited text no. 2
Tajima Y, Fukuda K, Tsuneoka N, Tsutsumi R, Kuroki T, Onizuka S, et al. Demonstration of a pancreaticopleural fistula with magnetic resonance cholangiopancreatography. Am J Surg 2004;187:741-2.  Back to cited text no. 3
Balasubramanian P, Jeyamani R, Govil S, Chacko A, Kurian C, Subhash HS, et al. Pancreatico-pericardial fistula: A rare complication of chronic pancreatitis. Indian J Gastroenterol 2004;23:31-2.  Back to cited text no. 4
Toporoff B, Sclafani S, Scalea T, Vieux E, Atweh N, Duncan A, et al. Percutaneous antegrade ureteral stenting as an adjunct for treatment of complicated ureteral injuries. J Trauma 1992;33:534-8.  Back to cited text no. 5
Wolf JH, Miller G, Ashinoff R, Dave J, Lefleur RS, Frangos SG, et al. Pancreaticoureteral fistula following penetrating abdominal trauma. JOP 2007;8:613-6.  Back to cited text no. 6
Donald GW, Hines JO. Pancreatic ductal disruptions leading to pancreatic fistula, pancreatic ascites or pancreatic pleural effusion. In: Cameron JL, editor. Current Surgical Therapy. 11 th ed. Philadelphia: Elsevier; 2014. p. 408-15.  Back to cited text no. 7
Bassi C, Butturini G, Molinari E, Mascetta G, Salvia R, Falconi M, et al. Pancreatic fistula rate after pancreatic resection. The importance of definitions. Dig Surg 2004;21:54-9.  Back to cited text no. 8
Barkin JS, Ferstenberg RM, Panullo W, Manten HD, Davis RC Jr. Endoscopic retrograde cholangiopancreatography in pancreatic trauma. Gastrointest Endosc 1988;34:102-5.  Back to cited text no. 9
Bradley EL 3 rd , Young PR Jr, Chang MC, Allen JE, Baker CC, Meredith W, et al. Diagnosis and initial management of blunt pancreatic trauma: Guidelines from a multiinstitutional review. Ann Surg 1998;227:861-9.  Back to cited text no. 10
Sica GT, Braver J, Cooney MJ, Miller FH, Chai JL, Adams DF. Comparison of endoscopic retrograde cholangiopancreatography with MR cholangiopancreatography in patients with pancreatitis. Radiology 1999;210:605-10.  Back to cited text no. 11
Al-Quorain AA, Ismail MH, Al-Mulhim AA, Yasawy MI, Elhassan AY, Al-Mulhim FA. Prospective comparative study of mrcp and ercp in biliary and pancreatic duct abnormalities. Sci J of King Faisal Univ 2010;11:193-201.  Back to cited text no. 12
Vitellas KM, Keogan MT, Spritzer CE, Nelson RC. MR Cholangiopancreatography of bile and pancreatic duct abnormalities with emphasis on the single-shot fast spin-echo technique. Radiographics 2000;20:939-57; quiz 1107-8, 1112.  Back to cited text no. 13
Hekimoglu K, Ustundag Y, Dusak A, Erdem Z, Karademir B, Aydemir S, et al. MRCP vs. ERCP in the evaluation of biliary pathologies: Review of current literature. J Dig Dis 2008;9:162-9.  Back to cited text no. 14
Hickey DP, Bakthavatsalam R, Bannon CA, O'Malley K, Corr J, Little DM. Urological complications of pancreatic transplantation. J Urol 1997;157:2042-8.  Back to cited text no. 15
Regueiro López JC, Padillo Ruiz FJ, Requena Tapia MJ, Alvarez Kindelan J, Carmona Campos E, Anglada Curado J. Urologic complications of pancreas-kidney simultaneous transplantation. Actas Urol Esp 1998;22:193-203.  Back to cited text no. 16
Voss M, PappasT. Pancreatic fistulas. Curr Treat Options Gastroenterol 2002;5:345-53.  Back to cited text no. 17
Chebli JM, Gaburri PD, de Souza AF, Ornellas AT, Martins Junior EV, Chebli LA, et al. Internal pancreatic fistulas: Proposal of a management algorithm based on a case series analysis. J Clin Gastroenterol 2004;38:795-800.  Back to cited text no. 18
Klek S, Sierzega M, Turczynowski L, Szybinski P, Szczepanek K, Kulig J. Enteral and parenteral nutrition in the conservative treatment of pancreatic fistula: A randomized clinical trial. Gastroenterology 2011;141:157-63, 163.e1.  Back to cited text no. 19
Prinz RA, Pickleman J, Hoffman JP. Treatment of pancreatic cutaneous fistulas with a somatostatin analog. Am J Surg 1988;155:36-42.  Back to cited text no. 20
Barnes SM, Kontny BG, Prinz RA. Somatostatin analog treatment of pancreatic fistulas. Int J Pancreatol 1993;14:181-8.  Back to cited text no. 21
Koti RS, Gurusamy KS, Fusai G, Davidson BR. Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: A Cochrane review. HPB (Oxford) 2010;12:155-65.   Back to cited text no. 22
Halttunen J, Weckman L, Kemppainen E, Kylänpää ML. The endoscopic management of pancreatic fistulas. Surg Endosc 2005;19:559-62.  Back to cited text no. 23
Boerma D, Rauws EA, van Gulik TM, Huibregtse K, Obertop H, Gouma DJ. Endoscopic stent placement for pancreaticocutaneous fistula after surgical drainage of the pancreas. Br J Surg 2000;87:1506-9.  Back to cited text no. 24
Bracher GA, Manocha AP, DeBanto JR, Gates LK Jr, Slivka A, Whitcomb DC, et al. Endoscopic pancreatic duct stenting to treat pancreatic ascites. Gastrointest Endosc 1999;49:710-5.  Back to cited text no. 25
Telford JJ, Farrell JJ, Saltzman JR, Shields SJ, Banks PA, Lichtenstein DR, et al. Pancreatic stent placement for duct disruption. Gastrointest Endosc 2002;56:18-24.  Back to cited text no. 26
Arvanitakis M, Delhaye M, Bali MA, Matos C, Le Moine O, Devière J. Endoscopic treatment of external pancreatic fistulas: When draining the main pancreatic duct is not enough. Am J Gastroenterol 2007;102:516-24.  Back to cited text no. 27


  [Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]

This article has been cited by
1 Role of enteral nutrition in pancreaticocolonic fistulas secondary to severe acute pancreatitis
Binxin Cui,Lu Zhou,Samiullah Khan,Jianmin Cui,Wentian Liu
Medicine. 2017; 96(49): e9054
[Pubmed] | [DOI]


Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  In this article
Case Presentation
Article Figures

 Article Access Statistics
    PDF Downloaded256    
    Comments [Add]    
    Cited by others 1    

Recommend this journal